BioSpace News Archive

Drug Development

First Patient Enrolled in Phase 1/2 “ELUCIDATE” Trial Assessing GTAEXS617 in Advanced Solid Tumours

Exscientia plc (Nasdaq: EXAI) today announced that it has enrolled the first patient in its Phase 1/2 “ELUCIDATE” (GTAEXS617-001) study evaluating GTAEXS617 (‘617), Exscientia’s precision-designed CDK7 inhibitor, for the treatment of advanced solid tumours.

July 10, 2023
·
6 min read
Pharm Country

KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60® Infusion System With Hizentra® 50 Ml Prefilled Syringes

KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60 ® Infusion System With Hizentra ® 50 Ml Prefilled Syringes.

July 10, 2023
·
2 min read
Business

Starton Therapeutics Contracts Global Clinical Research Organization to Conduct STAR-LLD Phase 1b Clinical Trial in Multiple Myeloma

Starton Therapeutics Inc. today entered into a definitive agreement to conduct its Phase 1b trial in multiple myeloma with a global Clinical Research Organization (CRO).

July 10, 2023
·
14 min read
Business

Former CDC Director and Renowned Physician-Scientist Dr. Robert Redfield Joins BPGbio Scientific Advisory Board

Dr. Redfield Joins Scientific Advisory Board as BPGBio Advances its Deep Portfolio of AI-Developed Late-Stage Therapeutics and Diagnostics.

July 10, 2023
·
4 min read
Bruker Enables Advanced Life-Science and Green-Tech Research in the UK

At the EUROMAR Conference 2023 in Scotland, Bruker showcases the latest innovations in magnetic resonance technology for life science and materials science research.

July 10, 2023
·
6 min read
FDA

US FDA approves expanded indication for Novartis Leqvio® (inclisiran) to include treatment of adults with high LDL-C and who are at increased risk of heart disease

Novartis announced today that the US Food and Drug Administration (FDA) has approved a label update for Leqvio® (inclisiran) to enable earlier use in patients with elevated LDL-C who have an increased risk of heart disease, as an adjunct to diet and statin therapy1.

July 10, 2023
·
10 min read
FDA

MyoPax Receives Rare Pediatric Disease Designation from FDA for Breakthrough Regenerative Cell Product in Exstrophy-Epispadias Complex

MyoPax Receives Rare Pediatric Disease Designation from FDA for Breakthrough Regenerative Cell Product in Exstrophy-Epispadias Complex.

July 10, 2023
·
2 min read
Pharm Country

Eli Lilly Selects ABEC for World’s Largest Single-Use Biopharmaceutical Manufacturing Facility

ABEC, a leader in engineered solutions and services for biotech manufacturing, announced it will deliver multiple Custom Single Run (CSR ® ) single-use systems to Eli Lilly’s next-generation biopharmaceutical manufacturing facility in Limerick, Ireland.

July 10, 2023
·
2 min read
Business

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2023 Financial Results on August 9, 2023

Organogenesis Holdings Inc. today announced that second quarter of fiscal year 2023 financial results will be reported after the market closes on Wednesday, August 9th.

July 10, 2023
·
1 min read
Business

Syneos Health Appoints Hillary Bochniak as Chief Human Resources Officer

Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, announced the appointment of Hillary Bochniak as Chief Human Resources Officer, effective July 10, 2023.

July 10, 2023
·
2 min read